![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » DxTerity Diagnostics’ Radiation Blood Test Receives CE Mark
DxTerity Diagnostics’ Radiation Blood Test Receives CE Mark
![](https://www.fdanews.com/ext/resources/test/Blood-Collection.gif?t=1433951859&width=450)
May 29, 2018
DxTerity Diagnostics received CE Mark certification for its REDI-Dx radiation biodosimetry test used to measure an absorbed ionizing radiation dose after a nuclear event.
The blood test gives individualized estimates of absorbed radiation from a peripheral blood sample and measures a patient’s biological response to radiation.
Physicians can use the blood test’s estimates in conjunction with clinical symptoms and radiation dispersal monitoring to prioritize patients for medical treatment.
Upcoming Events
-
21Oct